Paragon Care Ltd (ASX: PGC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Paragon Care Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$322.78 million
P/E Ratio
16.13
Dividend Yield
0.00%
Shares Outstanding
1.66 billion
Earnings per share
0.012
Dividend per share
0.01
Year To Date Return
-6.98%
Earnings Yield
6.20%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Paragon Care Ltd (ASX: PGC)
Latest News
⏸️ Investing
4 small-cap healthcare shares that you need to know about
⏸️ Investing
3 exciting healthcare shares for growth & income
⏸️ Investing
5 cheap quality small cap stocks for 2017
⏸️ Investing
Why Lifehealthcare Group Ltd shares popped 8% today
⏸️ Investing
Should you buy these 4 health care stocks?
⏸️ Investing
3 small-cap shares I'd buy with $5,000
⏸️ Investing
2 shares priced under $1 that I would buy today
⏸️ Investing
Why these 5 shares are soaring on the ASX today
⏸️ Investing
Paragon Care Ltd reports huge increase in sales and profits: Time to buy?
⏸️ Investing
Here's why these 4 ASX shares have rocketed today
⏸️ Investing
Paragon Care Ltd. shares soar on profit upgrade
⏸️ Investing
3 small companies that are a better investment than lithium miners
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 18 Sep 2023 | $0.0060 | 100.00% | Final | 06 Oct 2023 |
| 14 Mar 2023 | $0.0060 | 100.00% | Interim | 05 Apr 2023 |
| 12 Sep 2022 | $0.0060 | 100.00% | Final | 04 Oct 2022 |
| 21 Mar 2022 | $0.0060 | 100.00% | Interim | 26 Apr 2022 |
| 13 Sep 2021 | $0.0100 | 100.00% | Final | 01 Oct 2021 |
| 21 Mar 2019 | $0.0110 | 100.00% | Interim | 26 Apr 2019 |
| 14 Sep 2018 | $0.0200 | 100.00% | Final | 12 Oct 2018 |
| 15 Mar 2018 | $0.0110 | 100.00% | Interim | 12 Apr 2018 |
| 07 Sep 2017 | $0.0000 | 100.00% | Final | 06 Oct 2017 |
| 09 Mar 2017 | $0.0110 | 100.00% | Interim | 06 Apr 2017 |
| 15 Sep 2016 | $0.0140 | 100.00% | Final | 06 Oct 2016 |
| 09 Mar 2016 | $0.0080 | 100.00% | Interim | 06 Apr 2016 |
| 08 Oct 2014 | $0.0075 | 100.00% | Final | 31 Oct 2014 |
| 07 Mar 2014 | $0.0050 | 100.00% | Interim | 31 Mar 2014 |
| 04 Oct 2013 | $0.0100 | 100.00% | Final | 31 Oct 2013 |
PGC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Paragon Care Ltd
Paragon Care Ltd. engages in supplying medical equipment to the health and aged care markets. Its product categories include balance and mobility, beds, mattresses and furniture, carts and trolleys, consulting room equipment, dermatology and cosmetic medicine, general medical products, consumables, infection control, lighting, materials management, newborn care, operating theatre, and ophthalmic. The company was founded in 1994 and is headquartered in South Melbourne, Australia.
PGC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 13 Feb 2026 | $0.20 | $-0.01 | -5.00% | 70,622 | $0.20 | $0.20 | $0.20 |
| 12 Feb 2026 | $0.20 | $0.00 | 0.00% | 755,967 | $0.21 | $0.21 | $0.20 |
| 11 Feb 2026 | $0.20 | $0.00 | 0.00% | 465,394 | $0.21 | $0.21 | $0.20 |
| 10 Feb 2026 | $0.20 | $0.01 | 5.13% | 1,052,677 | $0.20 | $0.22 | $0.20 |
| 09 Feb 2026 | $0.20 | $0.00 | 0.00% | 1,094,578 | $0.20 | $0.20 | $0.20 |
| 06 Feb 2026 | $0.20 | $-0.01 | -4.88% | 1,117,372 | $0.21 | $0.21 | $0.20 |
| 05 Feb 2026 | $0.21 | $-0.01 | -4.76% | 458,989 | $0.21 | $0.21 | $0.20 |
| 04 Feb 2026 | $0.21 | $0.00 | 0.00% | 820,712 | $0.21 | $0.22 | $0.21 |
| 03 Feb 2026 | $0.21 | $0.00 | 0.00% | 404,003 | $0.22 | $0.22 | $0.21 |
| 02 Feb 2026 | $0.21 | $0.00 | 0.00% | 299,571 | $0.22 | $0.22 | $0.21 |
| 30 Jan 2026 | $0.21 | $-0.01 | -4.65% | 1,348,899 | $0.22 | $0.22 | $0.21 |
| 29 Jan 2026 | $0.22 | $0.01 | 4.76% | 945,444 | $0.22 | $0.22 | $0.21 |
| 28 Jan 2026 | $0.21 | $-0.01 | -4.65% | 616,114 | $0.22 | $0.22 | $0.21 |
| 27 Jan 2026 | $0.22 | $-0.01 | -4.55% | 1,052,452 | $0.22 | $0.22 | $0.21 |
| 23 Jan 2026 | $0.22 | $0.01 | 4.65% | 3,238,080 | $0.23 | $0.23 | $0.22 |
| 22 Jan 2026 | $0.22 | $-0.01 | -4.55% | 1,414,085 | $0.22 | $0.23 | $0.22 |
| 21 Jan 2026 | $0.22 | $0.00 | 0.00% | 498,327 | $0.22 | $0.22 | $0.21 |
| 20 Jan 2026 | $0.22 | $0.01 | 4.65% | 1,034,123 | $0.23 | $0.23 | $0.22 |
| 19 Jan 2026 | $0.22 | $-0.01 | -4.55% | 919,449 | $0.22 | $0.22 | $0.22 |
| 16 Jan 2026 | $0.22 | $-0.03 | -12.00% | 2,614,190 | $0.25 | $0.25 | $0.22 |
| 15 Jan 2026 | $0.25 | $0.01 | 4.08% | 288,718 | $0.25 | $0.26 | $0.25 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 30 Dec 2025 | David Collins | Buy | 2,000,000 | $438,400 |
On-market trade.
|
| 22 Dec 2025 | Carmen Riley | Buy | 2,000,000 | $360,000 |
On-market trade.
|
| 19 Dec 2025 | David Collins | Buy | 3,000,000 | $541,200 |
On-market trade.
|
| 19 Dec 2025 | John Walstab | Buy | 1,000,000 | $180,000 |
On-market trade.
|
| 09 Dec 2025 | Carmen Riley | Buy | 100,000 | $23,612 |
On-market trade.
|
| 08 Dec 2025 | Carmen Riley | Issued | 3,018,108 | $709,255 |
Issue of securities.
|
| 07 Nov 2025 | John Walstab | Transfer | 15,000,000 | $4,875,000 |
As advised by the company. Off-market transfer of 15,000,000 Shares to HSBC Custody
Nominees (Australia) Limited as custodian for Equities First Holdings LLC pursuant to the Master Loan Agreement and Deed of Security |
| 21 Oct 2025 | Peter Lacaze | Buy | 640,167 | $187,376 |
On-market trade.
|
| 21 Oct 2025 | David Collins | Buy | 640,167 | $187,376 |
On-market trade.
|
| 20 Oct 2025 | Peter Lacaze | Buy | 105,114 | $29,042 |
On-market trade.
|
| 20 Oct 2025 | David Collins | Buy | 105,114 | $29,042 |
On-market trade.
|
| 01 Oct 2025 | Peter Egglestone | Buy | 200,000 | $58,500 |
On-market trade.
|
| 01 Jul 2025 | Carmen Riley | Issued | 2,247,877 | $842,953 |
Issue of securities. 4,462,144 Performance Rights
|
| 26 Jun 2025 | Carmen Riley | Buy | 138,888 | $49,999 |
On-market trade.
|
| 11 Mar 2025 | Carmen Riley | Buy | 100,000 | $41,000 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Peter Andre Lacaze | Non-Executive ChairmanNon-Executive Director | Jun 2024 |
Mr Lacaze has been involved in CH2 Holdings since 2006 as a minority shareholder and served as Chief Executive Officer between 2006 and 2008. He became Chairman of CH2 Holdings in December 2015 when he and David Collins acquired 100% of CH2 Holdings. Peter is an experienced Australian business leader with a background in healthcare and travel industries, bringing a dynamic and practical approach focused on long-term business performance. He is member of Risk Committee.
|
| Mr Michael Sapountzis | Company Secretary | Nov 2024 |
--
|
| Ms Carmen Rose Riley | Chief Operating OfficerExecutive Director | Jun 2024 |
Ms Riley had a diverse career prior to joining the healthcare industry, with extensive experience in FMCG covering supply chain and operations, finance, and project management. She has strong financial and operational management skills gained from roles in both private and ASX listed companies.
|
| Mr David Keith Collins | Chief Executive OfficerManaging Director | Jun 2024 |
Mr Collins was appointed CEO and Managing Director of CH2 Holdings in December 2015 when he and Peter Lacaze acquired 100% of the company. He has been with CH2 Holdings since 2005, initially as Chief Financial Officer, then as Managing Director from 2008 to 2014. In 2006, he became a minority shareholder. David also spent 14 months as Chief Financial Officer at Greencross Health Limited in Auckland. He brings extensive knowledge of the Australian and New Zealand healthcare wholesale and distribution sectors and has held senior finance and management roles in pharmaceutical wholesaling industries in both countries.
|
| Mr Peter John Egglestone | Non-Executive Director | Mar 2025 |
Mr Peter is a senior executive with more than 25 years of leadership, financial, and commercial experience. He was CEO of one of Australia's leading payment facilitators and has held multiple C-suite roles, including positions at the private equity business Journey Beyond, where he led all revenue functions such as sales, marketing, revenue management, and customer relations. Peter has a background in finance and economics, with formative years spent in corporate and statutory accounting. He is Chair of Risk Committe.
|
| Marcus Crowe | Chief Financial Officer |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Cherie Maria Millar & David Keith Collins | 471,762,036 | 28.50% |
| Peter Andrew Lacaze & Dianne Maree Lacaze | 471,762,036 | 28.50% |
| Citicorp Nominees Pty Limited | 150,426,538 | 9.09% |
| Mr John Walstab | 143,956,314 | 8.70% |
| HSBC Custody Nominees (Australia) Limited | 82,137,176 | 4.96% |
| BNP Paribas Nominees Pty Ltd | 28,860,063 | 1.74% |
| J P Morgan Nominees Australia Pty Limited | 27,161,713 | 1.64% |
| First Samuel Ltd Acn 086243567 | 14,759,097 | 0.89% |
| BNP Paribas Nominees Pty Ltd()i | 8,285,064 | 0.50% |
| Phillip Graham Sidney Pty Ltd | 8,157,399 | 0.49% |
| Certane Ct Pty Ltd | 5,000,000 | 0.30% |
| Dixson Trust Pty Limited | 4,506,994 | 0.27% |
| Mrs Sandra Joan Mcdonald & Mr Andrew Mcdonald | 4,502,524 | 0.27% |
| Jmt Investment Group Vic Pty Ltd | 4,200,000 | 0.25% |
| Rathvale Pty Limited | 4,152,250 | 0.25% |
| Mr Richard Albarran | 3,942,129 | 0.24% |
| Mr Drew Townsend | 3,942,128 | 0.24% |
| Mr Richard Albarran (i) | 3,760,288 | 0.23% |
| Vista Tide Pty Limited | 3,507,122 | 0.21% |
| Snowball Fiduciary Pty Ltd | 3,209,000 | 0.19% |
| Jmt Investment Group Vic Pty Ltd (i) | 3,200,000 | 0.19% |
